Evidence map›Paper›PMID 40984702›Full record

ArticleBriefings in bioinformatics2025

SageTCR: a structure-based model integrating residue- and atom-level representations for enhanced TCR-pMHC binding prediction.

Xiangyi Li, Chuance Sun, Weiran Huang, Yanjing Wang, Buyong Ma

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiangyi LiEngineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Dongchuan Road, Minhang District, Shanghai 200240, China.ORCID 0009-0002-5885-6656
Chuance SunEngineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Dongchuan Road, Minhang District, Shanghai 200240, China.ORCID 0000-0003-0583-6280
Weiran HuangEngineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Dongchuan Road, Minhang District, Shanghai 200240, China.
Yanjing WangEngineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Dongchuan Road, Minhang District, Shanghai 200240, China.ORCID 0000-0001-6826-1635
Buyong MaEngineering Research Center of Cell & Therapeutic Antibody (MOE), School of Pharmacy, Shanghai Jiao Tong University, Dongchuan Road, Minhang District, Shanghai 200240, China.ORCID 0000-0002-7383-719X

Funding

National Natural Science Foundation of China 32171246National Natural Science Foundation of China 32200531Shanghai Municipal Government Science and Innovation Grant 21JC1403700
6 · The paper itself

Abstract

T-cell receptors (TCRs) recognize peptide-MHC (pMHC) complexes through intricate structural interactions, which is a core component of adaptive immunity. However, the diverse and cross-reactive nature of TCRs poses great challenges for accurate prediction of TCR-epitope interactions, hampering the advancement and broad application of TCR-related therapies. Here, we present SageTCR, a bi-level graph neural network (GNN) framework that leverages structural data to predict TCR-pMHC binding possibilities. Harnessing the pretrained language models, SageTCR encodes detailed structural arrangement at both residue-level and atomic-level and effectively integrates the bimodal representations via attention mechanisms. To tackle the deficiency of experimental structures, we explore comprehensive data augmentation strategies to enrich the training and increase the generalizability while concurrently preserving the characteristic TCR-pMHC diagonal binding mode. SageTCR demonstrates superior performance compared to six methods with different deep learning architectures. Furthermore, SageTCR offers the interpretability by identifying and focusing on the conformational features of pivotal contact residues on the interface, which can provide valuable insights for TCR engineering and immunotherapy design.

Indexed as

Histocompatibility AntigensPeptidesReceptors, Antigen, T-CellSoftwareDeep LearningHumansModels, MolecularNeural Networks, ComputerProtein BindingHistocompatibility AntigensPeptidesReceptors, Antigen, T-Cellbinding predictiondeep learninggraph sample and aggregate networksimmunologyTCR-antigen

Identifiers

PMID40984702
PMCPMC12454268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.